
Globax India Bio Pharmaceutical Private Limited
Produces pharmaceutical and medicinal chemicals and botanical products since 2015.
Produces pharmaceutical and medicinal chemicals and botanical products since 2015.
Globax India Bio Pharmaceutical Private Limited (GIBPPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 September 2015 (Nine years and five months 11 days old ). Its registered office is in Noida, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹2.69 Cr. The company has closed loans amounting to ₹1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Neeraj Sharma and Kusum Sharma serve as directors at the Company.
Noida, Uttar Pradesh, India
+91-XXXXXXXXXX
-
U33111UP2015PTC073477
073477
Private Limited Indian Non-Government Company
23 Sep 2015
30 Sep 2023
31 Mar 2023
Unlisted
Roc Kanpur
Name | Designation | Appointment Date | Status |
---|---|---|---|
Neeraj Sharma ![]() | Director | 23-Sep-2015 | Current |
Kusum Sharma ![]() | Director | 23-Sep-2015 | Current |
Globax India Bio Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.82% increase. The company also saw a slight improvement in profitability, with a 9.78% increase in profit. The company's net worth Soared by an impressive increase of 23.03%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Globax India Bio Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Neeraj Sharma and Kusum Sharma are mutual person
₹26.91 M
₹1.00 M
Date | Lender | Amount | Status |
---|---|---|---|
26 Sep 2022 | Yes Bank Limited | ₹1.00 Cr | Open |
13 Sep 2021 | Hdfc Bank Limited | ₹1.51 M | Open |
16 Sep 2020 | Others | ₹7.70 M | Open |
17 Jun 2019 | Hdfc Bank Limited | ₹2.20 M | Open |
16 Aug 2018 | State Bank Of India | ₹5.50 M | Open |
Unlock and access historical data on people associated with Globax India Bio Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Globax India Bio Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Globax India Bio Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Globax India Bio Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Globax India Bio Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Kanpur.
A charge with Yes Bank Limited amounted to Rs. 10.00 M with Charge ID 100622773 was registered on 26 Sep 2022.
A charge with Hdfc Bank Limited amounted to Rs. 1.51 M with Charge ID 100495196 was registered on 13 Sep 2021.
A charge with Others amounted to Rs. 7.70 M with Charge ID 100373968 was registered on 16 Sep 2020.
A charge with Hdfc Bank Limited amounted to Rs. 2.20 M with Charge ID 100287366 was registered on 17 Jun 2019.
Globax India Bio Pharmaceutical Private Limited was incorporated on 23 Sep 2015.
The authorized share capital of Globax India Bio Pharmaceutical Private Limited is ₹ 1.50 M and paid-up capital is ₹ 1.50 M.
Currently 2 directors are associated with Globax India Bio Pharmaceutical Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Globax India Bio Pharmaceutical Private Limited is B-59 Secgor-55, Noida, Uttar Pradesh, India, 201301.
The corporate identification number (CIN) of Globax India Bio Pharmaceutical Private Limited is U33111UP2015PTC073477 and the company number is 073477 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Globax India Bio Pharmaceutical Private Limited has risen by 11.82%.
The financial reports for the fiscal year 2023 indicates that The net worth of Globax India Bio Pharmaceutical Private Limited has experienced an upsurge of 23.03%.
As per the financial statements for fiscal Year 2023, The total open charges for Globax India Bio Pharmaceutical Private Limited amount to ₹ 2.69 Cr.
The most recent Balance Sheet for Globax India Bio Pharmaceutical Private Limited was filed with the ROC on 31 Mar 2023.